Obesity and type 2 diabetes are complex metabolic disorders linked to insulin resistance in skeletal muscle. Weight loss, a fundamental treatment for these conditions, has been shown to improve ...

The approval of medicines called “glucagon-like peptide (GLP-1) agonists” has led to major changes in how type 2 diabetes is managed. These medicines work in a different way than other medicines used ...

Obesity and type 2 diabetes are closely linked. Excess body fat can alter your body’s metabolic system, promote insulin resistance, and trigger inflammatory responses that affect how well your body ...

Aug. 26 (UPI) --The Food and Drug Administration on Monday approved Insulet's Omnipod 5 automated insulin delivery system for people with Type 2 diabetes. In 2022, the FDA signed off on the system for ...

The FDA cleared the first automated insulin dosing device for adults with type 2 diabetes, the agency announced on Monday. An interoperable automated glycemic controller, Insulet's SmartAdjust ...

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people with insulin-treated type 2 diabetes (T2D), a new randomized trial showed.